Premium
Sumatriptan for prevention of acute mountain sickness: randomized clinical trial
Author(s) -
Jafarian Sirous,
Gorouhi Farzam,
Salimi Shabnam,
Lotfi Jamshid
Publication year - 2007
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.21162
Subject(s) - sumatriptan , medicine , placebo , migraine , anesthesia , randomized controlled trial , clinical trial , effects of high altitude on humans , agonist , incidence (geometry) , placebo group , altitude sickness , physics , alternative medicine , receptor , pathology , optics , anatomy
To determine the impact of sumatriptan prophylaxis on acute mountain sickness (AMS) and altitude headache development within 24 hours of ascent, we designed a double-blind, randomized, clinical trial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom